Showing results (1-10 of 206) with videos related to
Sort By:
Pageof 21
Molecules (Basel, Switzerland)|May 7, 2025
Lead-Structure-Based Rigidization Approach to Optimize SirReal-Type Sirt2 InhibitorsMatthias Frei, Thomas Wein, Franz BracherInternational Journal of Molecular Sciences|October 29, 2025
Lead Structure-Based Hybridization Strategy Reveals Major Potency Enhancement of SirReal-Type Sirt2 InhibitorsMatthias Frei, Ricky Wirawan, Thomas Wein, et al.RSC Medicinal Chemistry|September 8, 2025
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD+ co-factor bindingRicky Wirawan, Matthias Frei, Anna Heider, et al.Molecules (Basel, Switzerland)|September 27, 2025
Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition StrategyRicky Wirawan, Simon A Huber, Thomas Wein, et al.Archiv Der Pharmazie|November 3, 2016
From Lead to Drug Utilizing a Mannich Reaction: The Topotecan StoryFranz Bracher, Tim TremmelPlanta Medica|April 24, 2015
Determination by GC-IT/MS of phytosterols in herbal medicinal products for the treatment of lower urinary tract symptoms and food products marketed in EuropeChristoph Müller, Franz BracherArchiv Der Pharmazie|July 9, 2004
New total synthesis of niphatesine C and norniphatesine C based on a Sonogashira reactionJürgen Krauss, Franz BracherMolecules (Basel, Switzerland)|November 14, 2023
Aza Analogs of the TRPML1 Inhibitor Estradiol Methyl Ether (EDME)Philipp Rühl, Franz BracherNatural Product Research|June 26, 2003
Total synthesis of both enantiomers of the macrocyclic lactone citreofuranFranz Bracher, Brigitte SchulteScientia Pharmaceutica|May 28, 2011
The gramine route to pyrido[4,3-b]indol-3-ones - identification of a new cytotoxic leadUwe Wollein, Franz BracherPageof 21